Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-09-27
2010-12-28
Davis, Zinna N (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S253050, C514S309000, C544S128000, C544S363000, C546S141000
Reexamination Certificate
active
07858619
ABSTRACT:
The present invention is directed to a compound of formula (I),wherein R1, R2, R3, R4, A, L and n are as defined herein, its pharmaceutical composition, preparation and uses as a MMP inhibitor.
REFERENCES:
patent: 5962471 (1999-10-01), Schudok et al.
patent: 102004031850 (2006-01-01), None
patent: WO 97/18194 (1997-05-01), None
patent: WO 03/016248 (2003-02-01), None
Ma, Dawei, et al., Tetrahydroisoquinoline based sulfonamide hydroxamates as potent matrix metalloproteinase inhibitors, Bioorganic and Medicinal Chemistry Letters 14 47-50, Jan. 2004.
Breitschopf Kristin
Hofmeister Armin
Matter Hans
Schudok Manfred
Ugolini Antonio
Bolcsak James W.
Davis Zinna N
sanofi-aventis
LandOfFree
Substituted tetrahydroisochinolines as MMP inhibitors,... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted tetrahydroisochinolines as MMP inhibitors,..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted tetrahydroisochinolines as MMP inhibitors,... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4166935